An EGFR‐targeting antibody-drug conjugate LR004‐VC‐MMAE sorted by
relevance

Admin08.10.2021

An EGFR‐targeting antibody-drug conjugate LR004‐VC‐MMAE

Admin11.08.2021

An EGFR‐targeting antibody-drug conjugate LR004‐VC‐MMAE

3805
Admin11.09.2021

An EGFR‐targeting antibody-drug conjugate LR004‐VC‐MMAE

7903
Admin10.08.2021

An EGFR‐targeting antibody-drug conjugate LR004‐VC‐MMAE

85010
Admin03.10.2021

An EGFR‐targeting antibody-drug conjugate LR004‐VC‐MMAE

8202
Admin05.08.2021

An EGFR‐targeting antibody-drug conjugate LR004‐VC‐MMAE

6605
Admin25.07.2021

An EGFR‐targeting antibody-drug conjugate LR004‐VC‐MMAE

5805
Admin06.09.2021

An EGFR‐targeting antibody-drug conjugate LR004‐VC‐MMAE

Admin22.08.2021

(PDF) An EGFR‐targeting antibody‐drug conjugate LR004‐VC

4009
Admin22.07.2021

Antibody Drug Conjugates for Cancer Therapy

Admin09.10.2021

[PDF] Antibody drug conjugates: Progress, pitfalls, and

9206
Admin29.07.2021

An EGFR‐targeting antibody-drug conjugate LR004‐VC‐MMAE

9708
Admin07.10.2021

Antibody-Drug Conjugate (ADC) and Cancer Therapy

3009
Admin14.09.2021

Therapy study with antibody-drug-conjugate, IMGN853, and

4302
Admin09.09.2021

Antibody Drug Conjugates for Cancer Therapy

65010
Admin11.08.2021

Anticancer activity of drug conjugates in head and neck

2001
Admin18.09.2021

(PDF) Antibody Drug Conjugates: A New Era in Personalized

7402
Admin31.08.2021

The synthesis of gold-EGFR antibody conjugates was

Admin05.08.2021

Enhancement of tumor uptake and therapeutic efficacy of

73010
Admin27.07.2021

Low affinity EGFR antibody demonstrated differential

Admin09.10.2021

In vitro targeting of EGFR- expressing cells using Au-C225

7705